By Erin Carron (Original source Yahoo Finance)
CHICAGO, Oct. 29, 2019 (GLOBE NEWSWIRE) — “Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today announced that Dr. Scott Gottlieb, MD, has joined its Board of Directors. Dr. Gottlieb will serve as an advisor to Tempus and its leadership team, leveraging his vast experience as a medical policy expert and public health advocate to support Tempus as it harnesses the power and promise of big data and artificial intelligence to personalize patient care.
Dr. Gottlieb most recently served as the 23rd Commissioner of the Food and Drug Administration (FDA), where he focused on developing innovative approaches to improving medical outcomes, reshaping healthcare delivery, and expanding patient choice and safety. Previously, he also served as the agency’s Deputy Commissioner for Medical and Scientific Affairs and as a Senior Advisor to the FDA Commissioner. During his time as a Senior Advisor to the Administrator of the Centers for Medicare and Medicaid Services, Dr. Gottlieb worked on the implementation of the Medicare drug benefit, where he supported policy work on quality improvement and the agency’s coverage process, particularly as it related to new medical technologies.”
Click to see more
Mark Esper on U.S. Strikes Against Iran and Economic Pressure
The US has launched more strikes against Iran at President Donald Trump’s direction, US Central Command said. Shortly afterward, Iranian media reported explosions in the…
Thought Leader: Mark Esper
Sheila Bair on Car Loans & Smart Buying Advice
 About one in 20 car loans made to young people are in serious delinquency. That’s the highest rate since the global financial crisis. Today…
Thought Leader: Sheila Bair
Dr. Sanjay Gupta: From Pro Soccer to Saving Lives
Once defending goals in Major League Soccer, Dr. Marshall Leonard now defends lives as a physician. Today, he shares the wisdom that carried him through life transitions. Plus, the time he faced Brazilian soccer legend, Ronaldinho. Dr.…
Thought Leader: Sanjay Gupta
Scott Gottlieb: Concerns Over Drug Trials in China
Thought Leader: Scott Gottlieb
Scott Gottlieb on the Future of FDA Innovation
Thought Leader: Scott Gottlieb
Scott Gottlieb on Ebola Outbreak
Thought Leader: Scott Gottlieb
